Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
The Medicare agency is on a path to potentially approve more new technology add-on payments for devices entering the hospital inpatient setting next year than it has since the NTAP program launched, even after disqualifying eight products under new eligibility requirements.
Left atrial appendage closure is a well-validated treatment to prevent stroke in AFib patients, but current device options do not allow physicians to streamline their practices to their needs. Conformal Medical’s CLAAS device, now in a large, randomized pivotal trial, was created to address a market ripe with growth while supporting greater case volumes and safer outcomes.
New guidelines on devices from outside contractors. Excerpted from Pathways’ Picks April 10: Reliance in Brazil, Manufacturing in China, Reprocessing in the EU, and More.